Background: Intravitreal injection has become a common procedure worldwide. A rare, but sight threatening, complication is bacterial endophthalmitis that has a poor visual prognosis. To identify practices that minimize the risk of endophthalmitis, the setting of a Danish University hospital is described.
Methods: A review of the intravitreal injection database of the department. All injections were performed in a positive pressure ventilated operating room under sterile conditions. The treating physicians wore face mask, the conjunctiva was irrigated twice with 5% povidone–iodine preoperatively, and topical tobramycin was applied immediately after the injection.
Results: The authors have performed a total of 20,293 injections were performed in 2,575 eyes. No cases of proven or suspected endophthalmitis were identified corresponding to a risk of 0% (95% confidence interval, 0–0.019) per injection and 0% (95% confidence interval, 0–0.15%) per patient. Approximately 7,000 injections, all in patients without diabetes, were treated without a course of topical antibiotics after the injection.
Conclusion: The department has had the lowest rate of endophthalmitis after intravitreal injections in the current literature. Several factors that could have contributed to the positive result are highlighted. Omitting a postoperative course of topical antibiotic appears safe in patients without diabetes.
The authors&#x0027; department has, to their knowledge, had the lowest rate of endophthalmitis after intravitreal injections in the current literature, and they highlight several factors that could have contributed to the authors&#x0027; positive results. Omitting a postoperative course of topical antibiotic appeared safe in patients without diabetes.
*Department of Ophthalmology, Copenhagen University Hospital, Roskilde, Denmark; and
†Clinical Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Reprint requests: Troels Brynskov, MD, Department of Ophthalmology, Copenhagen University Hospital, Køgevej 7-13, Roskilde DK-4000, Denmark; e-mail: email@example.com
None of the authors have any financial/conflicting interests to disclose.